Dr. Jay Bhattacharya, a Stanford professor of health policy, appears before the Senate HELP committee, which will vet his nomination to become the next director of the National Institutes of Health.
Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth. Dr. Jay Bhattacharya, NIH nominee, will shed stock in Walmart and Nvidia.
The panel of vaccine experts were supposed to hold their first meeting under the Trump administration in late February. It's not clear when that meeting will now take place.
As many as 1,300 probationary employees at CDC and 1,500 at NIH are losing their jobs. Many fear for the future of public health and scientific research.
Trump administration officials say the move was necessary "to build a culture of child safety and accountability." But advocates say they fear the administration will use it for immigration enforcement.
The pages that are set to be revived include information for patients about HIV testing and HIV prevention medication, guidance on contraceptives and data on adolescent and youth mental health.
Many groups that rely on a federal payment portal started experiencing problems accessing funds last week. HHS says "technical issues" are to blame and lag times continue.
In a letter, Kennedy said RFK Jr. was "unqualified" to be the new U.S. Department of Health and Human Services secretary just hours before he was scheduled to appear for confirmation hearings.
RFK Jr. plans to keep collecting referral fees in lawsuits against the drug company Merck even if confirmed as HHS secretary, according to new filings with the Office of Government Ethics.
In a memo obtained by NPR, acting Health Secretary Dorothy Fink forbade staff from public communications on most matters until Feb. 1, unless they get express approval from "a presidential appointee."
RFK Jr. wants to tackle chronic disease. Despite his widely disputed views on vaccines, his focus on healthy food and taking on special interests may find broad support — and face political headwinds.
Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty over how the president-elect will reconcile starkly different philosophies among the leaders of his team.
The Change Healthcare cyberattack sparked a new strategy from the federal government on preventing destructive ransomware crimes. Critics say it doesn't go far enough.
